Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Berotralstat (Orladeyo) for prevention of hereditary angioedema.
Journal: The Medical letter on drugs and therapeutics
Published: September 20, 2021
Reviewing clinical considerations and guideline recommendations of C1 inhibitor prophylaxis for hereditary angioedema.
Journal: Clinical and translational allergy
Published: August 03, 2021
Considerations for transition from subcutaneous to oral prophylaxis in the treatment of hereditary angioedema.
Journal: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
Published: April 13, 2021
Lanadelumab (Takhzyro) for prevention of hereditary angioedema.
Journal: The Medical letter on drugs and therapeutics
Published: March 23, 2021
Transition to lanadelumab-flyo from three medications for a hereditary angioedema patient with a variant in the SYTL2 gene: A case report.
Journal: Clinical case reports
Published: December 31, 2020
Pharmaceutical Approval Update.
Journal: P & T : a peer-reviewed journal for formulary management
Published: December 19, 2018
Showing 1-9 of 9
Last Updated: 10/31/2025